Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,050 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $1,498 | 18 | $0 (2023) |
| ITI, Inc. | $141.79 | 4 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $135.19 | 2 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $115.04 | 5 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $95.22 | 5 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $64.48 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $139.25 | 5 | Alkermes, Inc. ($54.69) |
| 2022 | $430.66 | 14 | ITI, Inc. ($141.79) |
| 2021 | $362.69 | 6 | Alkermes, Inc. ($223.23) |
| 2019 | $343.61 | 3 | Alkermes, Inc. ($343.61) |
| 2018 | $264.20 | 3 | Alkermes, Inc. ($249.98) |
| 2017 | $509.79 | 6 | Alkermes, Inc. ($509.79) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/29/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $36.14 | General |
| Category: Neurology | ||||||
| 09/26/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: Neuropsychiatry | ||||||
| 08/22/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Neuroscience | ||||||
| 07/25/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: CNS | ||||||
| 07/11/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: CNS | ||||||
| 11/01/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: PSYCHIATRY | ||||||
| 10/20/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Neuropsychiatry | ||||||
| 09/28/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: PSYCHIATRY | ||||||
| 09/15/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $92.29 | General |
| Category: CNS | ||||||
| 07/19/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: CNS | ||||||
| 06/21/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Neuropsychiatry | ||||||
| 05/17/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: PSYCHIATRY | ||||||
| 04/19/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Neuropsychiatry | ||||||
| 03/14/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: Neuroscience | ||||||
| 02/17/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $108.45 | General |
| Category: PSYCHIATRY | ||||||
| 02/11/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Neuroscience | ||||||
| 02/03/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Neuroscience | ||||||
| 11/17/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: PSYCHIATRY | ||||||
| 09/15/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $99.05 | General |
| Category: Central Nervous System | ||||||
| 09/02/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $110.12 | General |
| Category: CNS | ||||||
| 08/25/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: CNS | ||||||
| 07/20/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: NEUROLOGY | ||||||
| 06/17/2021 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $102.76 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 13 | 48 | $14,901 | $3,168 |
| 2021 | 1 | 11 | 40 | $12,418 | $3,148 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 13 | 48 | $14,901 | $3,168 | 21.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 11 | 40 | $12,418 | $3,148 | 25.4% |
About Dr. Daniela Reid, MD
Dr. Daniela Reid, MD is a Long Term Care Hospital healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1053467571.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniela Reid, MD has received a total of $2,050 in payments from pharmaceutical and medical device companies, with $139.25 received in 2023. These payments were reported across 37 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($2,050).
As a Medicare-enrolled provider, Reid has provided services to 24 Medicare beneficiaries, totaling 88 services with total Medicare billing of $6,316. Data is available for 2 years (2021–2022), covering 2 distinct procedure/service records.
Practice Information
- Specialty Long Term Care Hospital
- Other Specialties Psychiatry
- Location Phoenix, AZ
- Active Since 01/26/2007
- Last Updated 07/27/2021
- Taxonomy Code 282E00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053467571
Products in Payments
- Aristada 441 mg (Drug) $492.24
- ARISTADA (Drug) $492.09
- Vivitrol 380 mg (Drug) $267.53
- CAPLYTA (Drug) $141.79
- VIVITROL (Drug) $125.00
- LYBALVI (Drug) $121.62
- INVEGA SUSTENNA (Drug) $115.04
- AUSTEDO (Drug) $99.05
- INGREZZA (Drug) $95.22
- REXULTI (Drug) $43.56
- UZEDY (Drug) $36.14
- ABILIFY MAINTENA (Drug) $20.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Long Term Care Hospital Doctors in Phoenix
Dr. Dawood Mulla, M.d, M.D
Long Term Care Hospital
Dr. Lynn Lydon, M.d, M.D
Long Term Care Hospital
Dr. Ruby Ramos-Roxas, Md, MD
Long Term Care Hospital
Dr. Nasreen Qureshi, M.d, M.D
Long Term Care Hospital
M Akram Bhatti, M.d, M.D
Long Term Care Hospital